No­vo-part­nered mi­cro­cap biotech forced to halt PhI­II en­roll­ment in Rus­sia and Ukraine as war con­tin­ues

Rus­sia’s in­va­sion of Ukraine con­tin­ues to im­pact the bio­phar­ma in­dus­try, with a mi­cro­cap play­er an­nounc­ing Mon­day it will be forced to de­lay a piv­otal study …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER